/Eli%20Lilly%20%26%20Co_%20by%20Tada%20Images%20via%20Shutterstock.jpg)
Eli Lilly has expanded its partnership with Insilico Medicine to bring AI developed medicine into global market.
Centessa's OX2R agonist pipeline includes a potential best-in-class therapeutic with significant promise to meaningfully improve outcomes across a range of sleep-wake disorders
Futures tied to Canada's stock index moved higher on Monday, as commodity prices climbed amid a widening ...
Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz monotherapy in TOGETHER-PsA study
In the ADlong Phase 3b study, nearly all EBGLYSS-treated patients achieved meaningful skin improvement (EASI-75) for up to four years
Firing on All Cylinders: Eli Lilly (NYSE:LLY) Q4 Earnings Lead the Way
In today’s highly volatile market, this simple 3-ETF portfolio combines both steady income and long-term upside.
For the primary endpoint, retatrutide lowered A1C by an average of 1.7% to 2.0% across doses at 40 weeks in TRANSCEND-T2D-1
Five stocks recently traded by members of Congress—from AI defense to GLP-1 leaders—could offer clues for investors building their watchlists